Urology Research & Practice
Case Report

22-year survival following radical nephrectomy and several metastasectomies in a case of renal cell carcinoma

1.

Department of Urology, İstanbul University İstanbul School of Medicine, İstanbul, Turkey

2.

Department of Medical Oncology, Oncology Institute, Istanbul University İstanbul School of Medicine, İstanbul, Turkey

Urol Res Pract 2017; 43: 216-219
DOI: 10.5152/tud.2017.04372
Read: 1502 Downloads: 1012 Published: 25 July 2019

Abstract

Renal cell carcinoma (RCC) is a common malignancy. Metastases can be seen both synchronously, at the time of diagnosis, and metachronously during follow-up. At the time of diagnosis, 23% of the patients have metastatic disease. and 25% of patients will develop metastasis during follow-up period after nephrectomy. Nearly 80% of them develop within the first 5 years. However late metastasis of RCC have been also reported within the postoperative 10 years in the literature. For metastatic lesions, if surgically feasible, metastasectomy, and targeted pharmaceutical agents have been recommended. However any randomized controlled study which aimed to determine treatment protocol in patients who develop multiple metastases has not been cited in the literature. Herein, we are presenting a case with renal cell carcinoma in whom within 22 years of follow-up after 10 years of survival multiple metastases in different organs were detected which were managed with surgical, and medical treatments. As far as we know, this case is the first patient with the longest survival whose non-pulmonary metastases had been treated with more than one surgical interventions.

Files
EISSN 2980-1478